Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |